These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6799306)

  • 1. Long-term effects of nigro-striatal denervation of striatal [3H]haloperidol binding.
    Feuerstein C; Demenge P; Barrette G; Silice C; Guerin B; Mouchet P
    Eur J Pharmacol; 1981 Dec; 76(4):457-60. PubMed ID: 6799306
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 3. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum.
    Feuerstein C; Demenge P; Caron P; Barrette G; Guerin B; Mouchet P
    Brain Res; 1981 Dec; 226(1-2):221-34. PubMed ID: 7296288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
    Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine release in rat striatum: physiological coupling to tyrosine supply.
    During MJ; Acworth IN; Wurtman RJ
    J Neurochem; 1989 May; 52(5):1449-54. PubMed ID: 2496199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.
    MacKenzie RG; Stachowiak MK; Zigmond MJ
    Eur J Pharmacol; 1989 Sep; 168(1):43-52. PubMed ID: 2511032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
    Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
    Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in dopamine receptors: effect of lesion and haloperidol treatment.
    Goldstein M; Lew JY; Asano T; Ueta K
    Commun Psychopharmacol; 1980; 4(1):21-5. PubMed ID: 6105037
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia dopamine depletion does not alter D1 dopamine receptor binding properties.
    Trugman JM; Pronsky CJ; Wooten GF
    Adv Neurol; 1990; 53():107-10. PubMed ID: 2146858
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.
    Robertson GS; Vincent SR; Fibiger HC
    Brain Res; 1990 Jul; 523(2):288-90. PubMed ID: 2144781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophysectomy does not alter the increase in striatal dopamine receptor density produced by 6-hydroxydopamine lesions in male rats.
    Hruska RE
    Neurosci Lett; 1986 Jul; 68(2):207-10. PubMed ID: 3092152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution to the study of nigrostriatal dopaminergic neuron activity using electrochemical detection of dopamine release in the striatum of freely moving animals.
    Nieoullon A; Forni C; el Ganouni S
    Ann N Y Acad Sci; 1986; 473():126-40. PubMed ID: 3099623
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine depletion protects striatal neurons from ischemia-induced cell death.
    Clemens JA; Phebus LA
    Life Sci; 1988; 42(6):707-13. PubMed ID: 3123836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.